197 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Rank Status Study
1 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
2 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
3 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
4 Recruiting Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Conditions: HIV;   Malnutrition;   Cryptosporidiosis
Intervention:
5 Not yet recruiting Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
6 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
7 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
8 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
9 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
10 Recruiting Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
11 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
12 Recruiting The Combined Use of Indoor Residual Spraying (IRS) and Long-lasting Insecticidal Nets (LLINs) for Malaria Prevention
Condition: Malaria
Interventions: Other: Indoor residual spraying with bendiocarb;   Other: LLIN by universal coverage campaign
13 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME
14 Not yet recruiting Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil
Condition: Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine
15 Not yet recruiting High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Fluconazole;   Drug: Meglumine Antimoniate
16 Recruiting Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
Condition: Malaria
Intervention: Other: Artemether-lumefantrine
17 Unknown  Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
Condition: Malaria
Interventions: Biological: GMZ2 (malaria vaccine);   Biological: GMZ2 malaria vaccine;   Biological: Verorab vaccine
18 Recruiting Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants
Condition: Malaria
Interventions: Drug: Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy;   Drug: 3 dose dihydroartemisinin-piperaquine (DP) for adult women during pregnancy;   Drug: 3 dose sulfadoxine-pyrimethamine (SP) for adult women during pregnancy;   Drug: Monthly dihydroartemisinin-piperaquine (DP) for infants;   Drug: 3-monthly dihydroartemisinin-piperaquine (DP) for infants
19 Unknown  Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Condition: Malaria
Interventions: Biological: Malaria vaccine AMA1 (PfAMA-1-FVO[25-545];   Biological: AMA1
20 Recruiting Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A
Condition: Malaria
Interventions: Drug: Artemether-lumefantrine;   Drug: Dihydroartemisinin-piperaquine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years